Elon Musk asked a judge to block OpenAI's attempt to transition from nonprofit to for-profit. It's not the first time he's feuded with CEO Sam Altman.

OpenAI CEO Sam Altman will brief U.S. officials on super-agents—AI systems set to revolutionize software development, finance, and event planning.

"And of course it's smarter than us. Of course, it can do things we can't, but also who really cares? I think it's only weird for us in this one transition time."

The top tech companies Tuesday announced that they will create a new company, called Stargate, to grow artificial intelligence infrastructure in the United States. OpenAI CEO Sam Altman has shown support for Donald Trump,

Sam Altman has told OpenAI fans to lower their expectations after rumors the company had achieved AGI went viral on X.

Elon Musk and OpenAI CEO Sam Altman are in a dispute over the Stargate AI project proposed by Donald Trump, which aims to invest $500 billion in AI infrastructure. Musk questions the necessity of the funding while Altman defends the project as beneficial for the country.

The Stargate project, led by OpenAI's Sam Altman - to build the "world's largest AI infrastructure" - was announced by Donald Trump at a special press conference at the White House. Elon Musk, however,

The Stargate project, announced as a $500 billion initiative to create advanced AI systems and job opportunities, has drawn both skepticism and support. While Musk continues to criticize the venture’s funding, Altman maintains that the project is on track and aims to benefit the country significantly.

Sam Altman's comments came amid a flurry of online exchanges between himself, Musk, and Microsoft over the $500 billion Stargate Project announced by Trump.

Sam Altman, CEO of OpenAI, has publicly expressed his support for President Donald Trump. This revelation comes years after he praised LinkedIn co-founder Reid Hoffman for stopping his re-election.

Retro Biosciences is raising a $1bn round to fund the artificial intelligence-powered biotech’s mission to increase human lifespan by a decade, starting by getting its first drug into trials this year.